Superior Mesenteric Artery Thrombosis and Acute Intestinal Ischemia as a Consequence of COVID-19 Infection.
Abdominal Pain
/ etiology
Betacoronavirus
COVID-19
Coronavirus Infections
/ complications
Diarrhea
/ etiology
Embolectomy
Humans
Infarction
/ diagnosis
Intestines
/ blood supply
Ischemia
/ diagnostic imaging
Male
Mesenteric Artery, Superior
/ diagnostic imaging
Mesenteric Vascular Occlusion
/ diagnostic imaging
Middle Aged
Pandemics
Pneumonia, Viral
/ complications
SARS-CoV-2
Thrombectomy
Thrombosis
/ diagnostic imaging
Tomography, X-Ray Computed
Journal
The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566
Informations de publication
Date de publication:
29 Jul 2020
29 Jul 2020
Historique:
entrez:
30
7
2020
pubmed:
30
7
2020
medline:
2
9
2020
Statut:
epublish
Résumé
BACKGROUND The novel COVID-19 disease caused by the SARS-CoV-2 virus is a highly infectious disease that originated in Wuhan, China, and has rapidly spread throughout the world. In addition to respiratory complications, the virus has also been implicated in damage to other organ systems as well as coagulopathy. The present report describes the first presumptive case of COVID-19-associated acute superior mesenteric artery thrombosis and acute intestinal ischemia. CASE REPORT A 55-year old man presented to the emergency department with nausea, generalized abdominal pain and diarrhea; he denied having a fever or any respiratory symptoms. Computed tomography (CT) of the abdomen and pelvis revealed bilateral pulmonary ground-glass opacities. He tested positive for SARS-CoV-2, and was treated with hydroxychloroquine, azithromycin and ceftriaxone, and was discharged home after five days of inpatient treatment. One week later, the patient returned with recurrent nausea, vomiting and worsening diffuse abdominal pain. A CT scan of the abdomen showed a 1.6-cm clot, causing high grade narrowing of the proximal superior mesenteric artery and bowel ischemia. The patient emergently underwent exploratory laparotomy, thromboembolectomy and resection of the ischemic small bowel. A post-operative complete hypercoagulable workup was unrevealing. CONCLUSIONS Despite the absence of respiratory symptoms, patients infected with SARS-CoV-2 may show atypical presentations, such as gastrointestinal symptoms. Clinicians managing patients with suspected or confirmed SARS-CoV-2 infection during the COVID-19 pandemic should monitor these patients for potential complications that may arise from this disease.
Identifiants
pubmed: 32724028
pii: 925753
doi: 10.12659/AJCR.925753
pmc: PMC7417027
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e925753Références
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Swiss Med Wkly. 2020 Apr 11;150:w20247
pubmed: 32277760
Eur Heart J. 2020 May 14;41(19):1858
pubmed: 32227120
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
Am J Hematol. 2020 Jul;95(7):834-847
pubmed: 32282949
JAMA Intern Med. 2020 Mar 13;:
pubmed: 32167524
J Infect. 2020 Jun;80(6):656-665
pubmed: 32283155
Gastroenterology. 2020 Jul;159(1):81-95
pubmed: 32251668
Mil Med Res. 2020 Apr 20;7(1):19
pubmed: 32307014
N Engl J Med. 2020 Apr 23;382(17):e38
pubmed: 32268022
J Thromb Haemost. 2020 Jun;18(6):1514-1516
pubmed: 32278338
J Thromb Haemost. 2020 Jul;18(7):1752-1755
pubmed: 32267998
Eur Heart J. 2020 May 14;41(19):1859
pubmed: 32282027
Clin Gastroenterol Hepatol. 2020 Jun;18(7):1561-1566
pubmed: 32283325